This company focused on delivering innovative oncology and rare disease products to patients, Last january they had there highest market value for the year at 5.19, however, they slowly declined the following days, because they had to stop its services due to the pandemic, but as you can observe to its charts, the market just had an amazing break last march 18 and they had an upward success, recently, there market value rose up to 2.89 which is a good sign for being back as a bullish market.